APA (7th ed.) Citation

Häring, H., Merker, L., Seewaldt-Becker, E., Weimer, M., Meinicke, T., Broedl, U. C., & Woerle, H. J. (2014). Empagliflozin as Add-On to Metformin in Patients With Type 2 Diabetes: A 24-Week, Randomized, Double-Blind, Placebo-Controlled Trial. Diabetes Care, 37(6), 1650. https://doi.org/10.2337/dc13-2105

Chicago Style (17th ed.) Citation

Häring, Hans-Ulrich, Ludwig Merker, Elke Seewaldt-Becker, Marc Weimer, Thomas Meinicke, Uli C. Broedl, and Hans J. Woerle. "Empagliflozin as Add-On to Metformin in Patients With Type 2 Diabetes: A 24-Week, Randomized, Double-Blind, Placebo-Controlled Trial." Diabetes Care 37, no. 6 (2014): 1650. https://doi.org/10.2337/dc13-2105.

MLA (9th ed.) Citation

Häring, Hans-Ulrich, et al. "Empagliflozin as Add-On to Metformin in Patients With Type 2 Diabetes: A 24-Week, Randomized, Double-Blind, Placebo-Controlled Trial." Diabetes Care, vol. 37, no. 6, 2014, p. 1650, https://doi.org/10.2337/dc13-2105.